Auto Immune Panel
Auto Immune blood test panel checks ANA, RF/anti-CCP, thyroid antibodies, complement, immunoglobulins, and inflammation markers to guide next steps.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is not one test with one number. The Auto Immune panel is a bundled lab panel that looks at several immune and autoimmune markers together—autoantibodies, inflammation signals, complement proteins, and immunoglobulins—so you can interpret your results as a pattern instead of a single “positive/negative” headline.
Do I need this panel?
You may consider an Auto Immune panel if you have symptoms that could fit an autoimmune or immune-imbalance picture—things like persistent joint pain or swelling, unexplained fatigue, dry eyes or mouth, rashes, mouth ulcers, numbness/tingling, recurrent sinus or lung infections, or symptoms that come and go in “flares.”
This panel can also be useful when you already have one abnormal clue (for example, a positive ANA on a prior test, elevated inflammation markers, or a family history of autoimmune disease) and you want a clearer, more organized next step than ordering random add-on tests. Seeing multiple markers together can reduce false reassurance from one “normal” result and can also reduce catastrophizing from one isolated “positive” result.
You may not need this panel if you have a clear diagnosis with a specialist-directed monitoring plan (for example, a rheumatologist tracking a specific antibody and medication safety labs), or if your symptoms strongly point to a non-immune cause that should be evaluated first.
Your results are most useful when they support clinician-directed care. This panel can help you and your clinician decide what is likely, what is less likely, and what follow-up testing (or watchful waiting) makes sense for you.
Autoimmune and immune markers are method- and lab-dependent; reference ranges and reporting (especially ANA titer/pattern) can vary, so interpretation should use your lab’s ranges and your clinical context.
Lab testing
Order the Auto Immune panel
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order a multi-marker Auto Immune panel and get a single, organized report you can use for next steps. Instead of chasing individual tests across different visits, you can check a broad set of immune and autoimmune signals from one blood draw.
After your results post, you can use PocketMD to walk through what each category means (autoantibodies, inflammation, complement, immunoglobulins) and—more importantly—what the overall pattern suggests. That helps you prepare for a primary care or specialist visit with better questions and less uncertainty.
If your symptoms evolve, your clinician starts treatment, or you want to confirm whether a borderline finding persists, you can repeat this panel or expand to related panels so you can track trends over time rather than reacting to a single snapshot.
- One order, one draw: multiple immune and autoimmune markers bundled together
- Pattern-based interpretation support with PocketMD for multi-result reports
- Useful for pre-visit preparation and for trend tracking when retesting is appropriate
Key benefits of Auto Immune panel testing
- Helps you interpret a positive ANA in context instead of treating it as a diagnosis.
- Screens for common autoimmune-associated antibodies that can guide targeted follow-up.
- Pairs autoantibodies with inflammation markers to distinguish “signal” from background noise.
- Includes complement proteins that can add context when autoimmune activity is suspected.
- Assesses immunoglobulin levels (and subclasses) when recurrent infections or immune deficiency is part of the story.
- Reduces piecemeal testing by bundling related markers into one coordinated panel.
- Creates a baseline you can trend if symptoms change or treatment begins.
What is the Auto Immune panel?
The Auto Immune panel is a lab panel that measures multiple blood markers related to autoimmune activity and immune system function. It typically combines:
• Autoantibodies (antibodies that react to your own tissues), such as ANA (antinuclear antibody) and disease-associated antibodies like rheumatoid factor (RF) and anti-CCP. • Inflammation markers, such as CRP (C-reactive protein) and ESR (erythrocyte sedimentation rate), which reflect how activated your immune system is in a broad, non-specific way. • Complement proteins (often C3 and C4), which are part of the immune system and can shift in certain autoimmune patterns. • Immunoglobulins (IgG, IgA, IgM) and sometimes IgG subclasses, which help evaluate immune capacity—especially when recurrent infections, poor vaccine response, or chronic sinus/lung issues are concerns.
This panel does not “diagnose” an autoimmune disease on its own. Autoimmune conditions are diagnosed by combining symptoms, exam findings, imaging when needed, and lab patterns over time. The value of a panel is that it gives you a structured map: which immune pathways look quiet, which look activated, and which results are most worth discussing with a clinician.
Why a panel matters more than a single marker
Many immune tests are imperfect when used alone. ANA can be positive in healthy people, CRP can rise with infections or injury, and immunoglobulin levels can vary with stress, medications, and chronic illness. When you view them together, you can better separate a one-off abnormality from a consistent pattern that matches your symptoms.
What this panel can and cannot tell you
This panel can help identify whether your results lean toward autoimmune-associated antibodies, generalized inflammation, complement changes, or possible antibody deficiency. It cannot pinpoint the exact diagnosis without clinical correlation, and it cannot replace specialist evaluation when your symptoms are significant or progressive.
What do my panel results mean?
Mostly low/negative markers across the panel
If your autoantibodies are negative (for example, ANA negative, RF/anti-CCP negative), inflammation markers are low, complement is in range, and immunoglobulins are in range, the overall pattern is less supportive of an active systemic autoimmune process at the time of testing. That does not mean your symptoms are “not real,” and it does not fully rule out autoimmune disease—some conditions are seronegative, and some markers fluctuate. In this situation, the next step is usually symptom-guided evaluation (including non-immune causes), and retesting may be considered if new symptoms develop or if your clinician suspects an evolving condition.
Balanced immune pattern (reassuring overall context)
An “optimal” panel pattern generally means no strong autoimmune-associated antibody signal, inflammation markers that match how you feel (often low when you are well), complement levels that are stable, and immunoglobulins that suggest normal antibody production. If you have a low-titer ANA without other supportive findings, many clinicians interpret that as a non-specific finding—especially if you do not have classic autoimmune symptoms. The practical takeaway is that your immune system markers look balanced, and your clinician may focus on monitoring, targeted testing only if symptoms point to a specific condition, and addressing other contributors like thyroid disease, sleep, iron status, or chronic infections.
Elevated/positive markers that form a pattern
A “high” pattern can look different depending on which cluster is abnormal. A positive ANA with a higher titer and a consistent pattern, especially when paired with elevated CRP/ESR or low complement, can increase suspicion for autoimmune activity and usually warrants a clinician-guided workup rather than internet self-diagnosis. Positive RF and/or anti-CCP—particularly with joint pain, morning stiffness, or swelling—can be more specific for inflammatory arthritis patterns. Separately, abnormal immunoglobulins (very low IgG/IgA/IgM or unusual IgG subclass patterns) can point toward immune deficiency considerations, especially if your history includes recurrent sinopulmonary infections. The most important step is to interpret which markers agree with your symptoms and which may be incidental.
Factors that influence autoimmune and immune markers
Your panel results can shift with timing and context. Recent viral or bacterial infections can raise CRP/ESR and sometimes trigger transient autoantibodies. Pregnancy, aging, and some chronic conditions can be associated with low-titer ANA positivity without a systemic autoimmune disease. Medications can also change results: immunosuppressants and steroids may lower inflammation markers and antibody signals, while certain drugs are linked with drug-induced autoantibodies. Complement levels can be affected by acute inflammation, liver function, and immune consumption patterns. Immunoglobulins can be influenced by protein loss (kidney or gut), certain medications, and underlying immune disorders. If a result surprises you, it is reasonable to confirm it, review your recent illness and medication history, and interpret it with pretest probability—how well your symptoms match the condition the marker is meant to support.
Biomarkers included in this panel
- Ana Screen, Immunoassay
- Rheumatoid Factor
- Dna (Ds) Antibody
Frequently Asked Questions
Does a positive ANA mean you have an autoimmune disease?
Not by itself. ANA is a sensitive screening marker, but it is not specific—some healthy people have a positive ANA, and ANA can be transient after infections. The Auto Immune panel helps by adding context (titer, pattern, other antibodies, inflammation markers, complement, and immunoglobulins) so your clinician can judge whether the overall pattern matches your symptoms.
What is the difference between ANA titer and ANA pattern?
The titer reflects how strongly ANA is detected (reported as a dilution such as 1:80, 1:160, etc.), while the pattern describes how staining appears under the microscope (for example, homogeneous, speckled, nucleolar, centromere). Pattern and titer can influence how clinicians think about follow-up testing, but neither is diagnostic on its own.
When do RF and anti-CCP matter most?
RF and anti-CCP are most helpful when you have symptoms that fit inflammatory arthritis—joint swelling, prolonged morning stiffness, and pain in a pattern typical for rheumatoid arthritis. Anti-CCP is generally more specific than RF. If these antibodies are positive without compatible symptoms, your clinician may monitor or look for alternative explanations rather than labeling a diagnosis immediately.
Why are complement C3 and C4 included?
Complement proteins are part of immune signaling. In some autoimmune patterns, complement can be lower than expected due to immune consumption, while in other situations it can be normal or elevated as part of inflammation. Including C3 and C4 can add context when autoantibodies and symptoms raise concern for systemic autoimmune activity.
What do immunoglobulins and IgG subclasses tell you?
Total immunoglobulins (IgG, IgA, IgM) help assess whether your body is producing antibodies appropriately. IgG subclasses can add detail when recurrent sinus or lung infections, poor response to vaccines, or immune deficiency is being considered. Subclass results are easy to over-interpret, so they are best read alongside your infection history and, when needed, functional antibody testing ordered by a clinician.
Do I need to fast for the Auto Immune panel?
Fasting is usually not required for the markers commonly included in this panel. If you are combining this panel with other tests (like lipids or glucose/insulin testing), fasting requirements may change. Follow the instructions provided with your order.
Is it better to order a panel or individual tests?
A panel is often more efficient when your symptoms are non-specific or when you want to interpret an existing abnormal result (like a positive ANA) in context. Individual tests can be appropriate when a clinician already has a narrow diagnostic question or is monitoring a known condition. The right approach depends on your pretest probability and the decisions you need the results to inform.